Crystal Structure
Crystallisation Method: X-ray
Corresponding Chain: A
Sequence Length: 1-492
Detail: Struture Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0251 | ||||
Gene Name | SLC2A1 | ||||
Protein Name | Glucose transporter type 1, erythrocyte/brain | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Crystal Structure Crystallisation Method: X-ray Corresponding Chain: A Sequence Length: 1-492 Detail: Struture Info |
||||
Synonyms | CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1 | ||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Sugar Porter (SP) Family | |||||
Tissue Specificity | Detected in erythrocytes (at protein level).Expressed at variable levels in many human tissues. | ||||
Function | This transporter has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses. Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. | ||||
Endogenous Substrate(s) | Dehydroascorbate; Arsenite; D-glucose | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(α) Mutation-induced Structural Variation |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
D-glucose
|
Approved | Drug Info | Hypoglycemia | 5A21; 5A41 | [1] |
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
2-Deoxyglucose
|
Phase 1/2 | Drug Info | Cancer | 2A00-2F9Z | [3] |
Phase 3 Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Quercetin
|
Phase 3 | Drug Info | Coronary artery disease | BA6Z | [2] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
3-hydroxybutyrate | EM Info | Unclear experiment used for identifying this EM | [4] | ||
Drug-DT Affinity Assessed by Cell Line |
|||||
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
Dehydroascorbic acid | Investigative | Drug Info | Chinese hamster ovary (CHO) cells-GLUT1 | Km = 1100 microM | [5] |
References | |||||
1 | The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38. | ||||
2 | Oral Bioavailability and Disposition of Phytochemicals | ||||
3 | Glutamine 161 of Glut1 glucose transporter is critical for transport activity and exofacial ligand binding. J Biol Chem. 1994 Aug 12;269(32):20533-8. | ||||
4 | Epigenetic regulation of the glucose transporter gene Slc2a1 by beta-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice. Genes Cells. 2017 Jan;22(1):71-83. | ||||
5 | Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997 Jul 25;272(30):18982-9. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.